The Financial Comet
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

The Financial Comet

Investing

Rick Rule: Where I See 10+ Bagger Potential, Plus Gold Price, Stocks and M&A

by admin March 9, 2025
March 9, 2025
Rick Rule: Where I See 10+ Bagger Potential, Plus Gold Price, Stocks and M&A

Rick Rule sees people making mistakes, and he’s preparing to reap the benefits.

‘I’m looking to deploy reasonable amounts of money into something that I feel as a speculator over five years could be a 10 bagger or a 20 bagger. And there’s five or six of those out there right now, so I’m pretty excited,’ said the proprietor of Rule Investment Media.

Watch the interview above for more from Rule on those topics and others.

You can also click here to sign up for the Rule Symposium, set to run from July 7 to 11, 2025, in Boca Raton, Florida. Our full Prospectors & Developers Association of Canada convention playlist is here.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

previous post
Europe scrambles to rearm as Trump threatens security guarantees and Russian threat looms. Here’s what to know
next post
JD Vance says he was confronted by pro-Ukrainian protesters while walking with toddler daughter

Related Posts

Glencore to Close Last Australian Copper Mines, Smelter’s...

July 25, 2025

Q1 2025 Interim Financial Statements

May 14, 2025

Green Technology Metals: Delivering the Next Lithium Hub...

September 18, 2025

Crypto Market Recap: House Democrats to Launch Meme...

March 2, 2025

Jeff Clark: When Will Gold Stocks Move? Data...

January 29, 2025

Mobile Gaming Stocks: 10 Biggest Companies in 2025

June 17, 2025

Tech 5: Softbank to Invest US$2 Billion in...

August 24, 2025

Metallurgical Drilling Confirms Historic Grades at the Byro...

February 25, 2025

High-grade results incl 16m @ 8g/t Au in...

May 20, 2025

5 Best-performing Canadian Pharma Stocks of 2025

July 30, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 2

      DeepSeek hit with large-scale cyberattack, says it’s limiting registrations

      January 28, 2025
    • 3

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 27, 2025
    • 4

      Bank of America CEO says financial industry will jump into crypto payments if regulators allow it

      January 23, 2025
    • 5

      UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian Thompson killing

      January 27, 2025
    • 6

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • 7

      Lara Trump to host weekend show on Fox News

      February 7, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: thefinancialcomet.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 thefinancialcomet.com | All Rights Reserved